- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Hyperion Therapeutics Inc+ Add to Watchlist
HPTX:US24.6200 USD 1.3700 5.27%
As of 20:10:00 ET on 09/19/2014.
Company Profile for Hyperion Therapeutics Inc (HPTX)
Hyperion Therapeutics Inc. operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.
Hyperion Therapeutics Inc
Key Executives for Hyperion Therapeutics Inc (HPTX)
|James I Healy "Jim"Chairman||Donald J SantelChief Executive Officer|
|Jeffrey S FarrowChief Financial Officer||Bruce F ScharschmidtSenior VP/Chief Medical Ofcr|
|Christine A NashSenior VP/Chief Commercial Ofcr||Ashley C GouldSenior VP:Governmental Affairs|
|Natalie C HollesSenior VP:Corp Bus Development|